Literature DB >> 20179100

Ca2+ influx and protein scaffolding via TRPC3 sustain PKCbeta and ERK activation in B cells.

Takuro Numaga1, Motohiro Nishida, Shigeki Kiyonaka, Kenta Kato, Masahiro Katano, Emiko Mori, Tomohiro Kurosaki, Ryuji Inoue, Masaki Hikida, James W Putney, Yasuo Mori.   

Abstract

Ca(2+) signaling mediated by phospholipase C that produces inositol 1,4,5-trisphosphate [Ins(1,4,5)P(3)] and diacylglycerol (DAG) controls lymphocyte activation. In contrast to store-operated Ca(2+) entry activated by Ins(1,4,5)P(3)-induced Ca(2+) release from endoplasmic reticulum, the importance of DAG-activated Ca(2+) entry remains elusive. Here, we describe the physiological role of DAG-activated Ca(2+) entry channels in B-cell receptor (BCR) signaling. In avian DT40 B cells, deficiency of transient receptor potential TRPC3 at the plasma membrane (PM) impaired DAG-activated cation currents and, upon BCR stimulation, the sustained translocation to the PM of protein kinase Cbeta (PKCbeta) that activated extracellular signal-regulated kinase (ERK). Notably, TRPC3 showed direct association with PKCbeta that maintained localization of PKCbeta at the PM. Thus, TRPC3 functions as both a Ca(2+)-permeable channel and a protein scaffold at the PM for downstream PKCbeta activation in B cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179100      PMCID: PMC2831761          DOI: 10.1242/jcs.061051

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  64 in total

Review 1.  BLNK: connecting Syk and Btk to calcium signals.

Authors:  T Kurosaki; S Tsukada
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Protein kinase calpha targeting is regulated by temporal and spatial changes in intracellular free calcium concentration [Ca(2+)](i).

Authors:  C Maasch; S Wagner; C Lindschau; G Alexander; K Buchner; M Gollasch; F C Luft; H Haller
Journal:  FASEB J       Date:  2000-08       Impact factor: 5.191

Review 3.  Transient receptor potential channels as molecular substrates of receptor-mediated cation entry.

Authors:  T Hofmann; M Schaefer; G Schultz; T Gudermann
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

4.  Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound.

Authors:  Shigeki Kiyonaka; Kenta Kato; Motohiro Nishida; Kazuhiro Mio; Takuro Numaga; Yuichi Sawaguchi; Takashi Yoshida; Minoru Wakamori; Emiko Mori; Tomohiro Numata; Masakazu Ishii; Hiroki Takemoto; Akio Ojida; Kenta Watanabe; Aya Uemura; Hitoshi Kurose; Takashi Morii; Tsutomu Kobayashi; Yoji Sato; Chikara Sato; Itaru Hamachi; Yasuo Mori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

5.  Deletion of TRPC3 in mice reduces store-operated Ca2+ influx and the severity of acute pancreatitis.

Authors:  Min Seuk Kim; Jeong Hee Hong; Qin Li; Dong Min Shin; Joel Abramowitz; Lutz Birnbaumer; Shmuel Muallem
Journal:  Gastroenterology       Date:  2009-07-19       Impact factor: 22.682

6.  RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels.

Authors:  Shigeki Kiyonaka; Minoru Wakamori; Takafumi Miki; Yoshitsugu Uriu; Mio Nonaka; Haruhiko Bito; Aaron M Beedle; Emiko Mori; Yuji Hara; Michel De Waard; Motoi Kanagawa; Makoto Itakura; Masami Takahashi; Kevin P Campbell; Yasuo Mori
Journal:  Nat Neurosci       Date:  2007-05-13       Impact factor: 24.884

7.  TRPC3 channels are required for synaptic transmission and motor coordination.

Authors:  Jana Hartmann; Elena Dragicevic; Helmuth Adelsberger; Horst A Henning; Martin Sumser; Joel Abramowitz; Robert Blum; Alexander Dietrich; Marc Freichel; Veit Flockerzi; Lutz Birnbaumer; Arthur Konnerth
Journal:  Neuron       Date:  2008-08-14       Impact factor: 17.173

8.  TRPC channels promote cerebellar granule neuron survival.

Authors:  Yichang Jia; Jian Zhou; Yilin Tai; Yizheng Wang
Journal:  Nat Neurosci       Date:  2007-04-01       Impact factor: 24.884

Review 9.  Calcium signalling in lymphocyte activation and disease.

Authors:  Stefan Feske
Journal:  Nat Rev Immunol       Date:  2007-08-17       Impact factor: 53.106

10.  TRPC3 controls agonist-stimulated intracellular Ca2+ release by mediating the interaction between inositol 1,4,5-trisphosphate receptor and RACK1.

Authors:  Bidhan C Bandyopadhyay; Hwei L Ong; Timothy P Lockwich; Xibao Liu; Biman C Paria; Brij B Singh; Indu S Ambudkar
Journal:  J Biol Chem       Date:  2008-08-28       Impact factor: 5.157

View more
  26 in total

Review 1.  What is the evidence for the role of TRP channels in inflammatory and immune cells?

Authors:  A Parenti; F De Logu; P Geppetti; S Benemei
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

2.  The transient receptor potential (TRP) channel TRPC3 TRP domain and AMP-activated protein kinase binding site are required for TRPC3 activation by erythropoietin.

Authors:  Iwona Hirschler-Laszkiewicz; Qin Tong; Kathleen Waybill; Kathleen Conrad; Kerry Keefer; Wenyi Zhang; Shu-jen Chen; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

Review 3.  Divalent cation signaling in immune cells.

Authors:  Benjamin Chaigne-Delalande; Michael J Lenardo
Journal:  Trends Immunol       Date:  2014-06-02       Impact factor: 16.687

4.  TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN.

Authors:  Takuro Numaga-Tomita; Tsukasa Shimauchi; Sayaka Oda; Tomohiro Tanaka; Kazuhiro Nishiyama; Akiyuki Nishimura; Lutz Birnbaumer; Yasuo Mori; Motohiro Nishida
Journal:  FASEB J       Date:  2019-06-04       Impact factor: 5.191

5.  Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation.

Authors:  Masahide Harada; Xiaobin Luo; Xiao Yan Qi; Artavazd Tadevosyan; Ange Maguy; Balazs Ordog; Jonathan Ledoux; Takeshi Kato; Patrice Naud; Niels Voigt; Yanfen Shi; Kaichiro Kamiya; Toyoaki Murohara; Itsuo Kodama; Jean-Claude Tardif; Ulrich Schotten; David R Van Wagoner; Dobromir Dobrev; Stanley Nattel
Journal:  Circulation       Date:  2012-09-19       Impact factor: 29.690

6.  Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.

Authors:  Ruilian Ma; Jialiang Liang; Wei Huang; Linlin Guo; Wenfeng Cai; Lei Wang; Christian Paul; Huang-Tian Yang; Ha Won Kim; Yigang Wang
Journal:  Antioxid Redox Signal       Date:  2017-01-12       Impact factor: 8.401

7.  Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis.

Authors:  Youakim Saliba; Ralph Karam; Viviane Smayra; Georges Aftimos; Joel Abramowitz; Lutz Birnbaumer; Nassim Farès
Journal:  J Am Soc Nephrol       Date:  2014-12-05       Impact factor: 10.121

8.  Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes.

Authors:  Kazuhiro Nishiyama; Takuro Numaga-Tomita; Yasuyuki Fujimoto; Tomohiro Tanaka; Chiemi Toyama; Akiyuki Nishimura; Tomohiro Yamashita; Naoya Matsunaga; Satoru Koyanagi; Yasu-Taka Azuma; Yuko Ibuki; Koji Uchida; Shigehiro Ohdo; Motohiro Nishida
Journal:  Br J Pharmacol       Date:  2019-08-06       Impact factor: 8.739

9.  Pdx-1 activates islet α- and β-cell proliferation via a mechanism regulated by transient receptor potential cation channels 3 and 6 and extracellular signal-regulated kinases 1 and 2.

Authors:  Heather L Hayes; Larry G Moss; Jonathan C Schisler; Jonathan M Haldeman; Zhushan Zhang; Paul B Rosenberg; Christopher B Newgard; Hans E Hohmeier
Journal:  Mol Cell Biol       Date:  2013-08-12       Impact factor: 4.272

10.  TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy.

Authors:  Tsukasa Shimauchi; Takuro Numaga-Tomita; Tomoya Ito; Akiyuki Nishimura; Ryosuke Matsukane; Sayaka Oda; Sumio Hoka; Tomomi Ide; Norimichi Koitabashi; Koji Uchida; Hideki Sumimoto; Yasuo Mori; Motohiro Nishida
Journal:  JCI Insight       Date:  2017-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.